Clinical Cardiology 1408 - Clinical Cardiology Alert - Aug 01, 2010

Target Audience:

This activity is intended for the cardiologist.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Physician Editor
Michael H. Crawford, MD
Professor of Medicine
Chief of Cardiology
University of California
San Francisco

Editorial Board Members
Andrew J. Boyle, MBBS, PhD
Assistant Professor of Medicine
Interventional Cardiology
University of California
San Francisco

John P. DiMarco, MD, PhD
Professor of Medicine
Division of Cardiology
University of Virginia

Peer Reviewer
Ethan Weiss, MD
Assistant Professor of Medicine
Division of Cardiology and CVRI
University of California, San Francisco


  • Bleeding Avoidance Strategies and PCI
  • Bleeding with Dual-antiplatelet Therapy
  • Performance of a Bleeding-risk Score
  • Management of Antithrombotic Therapy with Device Placement
  • Left Main PCI vs. CABG: Five-year Follow-up of Two Registries
  • Management of Recalled ICD Leads
  • Exercise Training for POTS


  • to present the latest information regarding diagnosis and treatment of cardiac disease
  • to discuss the pros and cons of these interventions, as well as possible complications
  • to discuss the pros, cons, and cost-effectiveness of new and traditional diagnostic tests
  • to present current data regarding outpatient care of cardiac patients

Financial Disclosure:

Clinical Cardiology Alert’s physician editor, Michael H. Crawford, MD, is on the speaker’s bureau for Astra-Zenica. Editorial board member Andrew J. Boyle, MBBS, PhD, and peer reviewer, Ethan Weiss, MD, report no consultant, stockholder, speaker’s bureau, or other financial relationship with any company related to this field of study. Editorial board member John P. DiMarco, MD, PhD receives grant/research support from St. Jude Medical, Astellas, and Novartis, is a consultant for Medtronic & Sanofi-Aventis, and is a speaker for St. Jude Medical and Boston Scientific.

Copyright 2010 AHC Media. All rights reserved.